| 000 | 01532 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513211351.0 | ||
| 264 | 0 | _c20000626 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(00)00201-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, J M | |
| 245 | 0 | 0 |
_aTargeting antigen-specific T cells by genetically engineered antigen presenting cells. A strategy for specific immunotherapy of autoimmune disease. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cJul 2000 |
||
| 300 |
_a145-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xpharmacology |
| 650 | 0 | 4 |
_aAntigen-Presenting Cells _xphysiology |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xtherapy |
| 650 | 0 | 4 | _aEpitopes |
| 650 | 0 | 4 | _aFas Ligand Protein |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Targeting _xmethods |
| 650 | 0 | 4 | _aGenetic Engineering |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_afas Receptor _ximmunology |
| 700 | 1 | _aWu, B | |
| 700 | 1 | _aGuarnieri, F | |
| 700 | 1 | _aAugust, J T | |
| 700 | 1 | _aDrachman, D B | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 106 _gno. 1-2 _gp. 145-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(00)00201-0 _zAvailable from publisher's website |
| 999 |
_c10766541 _d10766541 |
||